跳至主要内容
临床试验/EUCTR2004-002981-39-GB
EUCTR2004-002981-39-GB进行中(未招募)1 期

Randomised trial of detrusor botulinum toxin injection (BOTOX®) compared to placebo in women with idiopathic detrusor overactivity

niversity Hospitals of Leicester NHS Trust0 个研究点目标入组 240 人开始时间: 2005年2月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Age over 18
  • Women with urodynamically proven detrusor overactivity unresponsive to oral medication defined as:
  • 8 weeks of continued treatment with any licensed anticholinergic drug, with a screening Patient Global Impression of Improvement (PGI-I) scale score of a little better” or worse.
  • 8 weeks of continued treatment, with a verbal response that the treatment has not provided acceptable improvement
  • Treatment stopped because of side effects within 8 weeks
  • Previous treatments stopped because of lack of efficacy, and currently receiving no treatment
  • ·At least 8 voids per 24 hours
  • ·At least 2 urgency episodes per 24 hours
  • ·Patients who have given fully informed written consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with known multiple sclerosis, stroke, spinal injury, or other neurological disease
  • Patients with pre-existing voiding dysfunction (flow rate less than 5th centile, or post void residual volume greater than 100ml)
  • Patients fulfilling the exclusion criteria for the licensed indications of botulinum toxin (myasthenia gravis and Eaton Lambert syndrome, or allergy to constituents of BOTOX® injection)
  • Patients with co-existing urodynamic stress incontinence

研究者

发起方
niversity Hospitals of Leicester NHS Trust

相似试验

Randomised trial of detrusor botulinum toxin... | 临床试验